Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
03 2019
Historique:
received: 07 09 2018
accepted: 27 11 2018
pubmed: 19 1 2019
medline: 25 6 2019
entrez: 19 1 2019
Statut: ppublish

Résumé

The aim of the study was to examine trends in the incidence and case fatality of acute myocardial infarction (AMI) and in hospital admissions for angina and coronary revascularisation procedures in people with type 2 diabetes and in people without diabetes in Scotland between 2006 and 2015. In this retrospective cohort study, AMI, angina and revascularisation event data were obtained for adults from hospital admissions and death records linked to a population-based diabetes register. Incidence by diabetes status was estimated using negative binomial models with adjustment or stratification by age, sex, deprivation and calendar year. Logistic regression was used to estimate AMI case fatality by diabetes status. There were 129,926 incident AMI events, 41,263 angina admissions and 69,875 coronary revascularisation procedures carried out during 34.9 million person-years of follow-up. The adjusted incidence of AMI, angina and revascularisation procedures declined by 2.0% (95% CI 1.73%, 2.26%), 9.62% (95% CI 9.22%, 10.01%) and 0.35% (95% CI -0.09%, 0.79%) per year, respectively. The rate of decline did not differ materially by diabetes status. RRs of AMI for type 2 diabetes were 1.86 (95% CI 1.74, 1.98) for men and 2.32 (95% CI 2.15, 2.51) for women. Of the 77,211 people admitted to hospital with a first AMI, 7842 (10.2%) died within 30 days of admission. Case fatality was higher in people with type 2 diabetes than in people without diabetes and declined in both groups by 7.93% (95% CI 7.03%, 8.82%) per year. The incidence of AMI, angina, revascularisation and AMI case fatality has declined over time, but the increased risk associated with type 2 diabetes has remained approximately constant.

Identifiants

pubmed: 30656362
doi: 10.1007/s00125-018-4796-7
pii: 10.1007/s00125-018-4796-7
pmc: PMC7019674
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

418-425

Subventions

Organisme : Chief Scientist Office
ID : PDF/15/07
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201492/Z/16/Z
Pays : United Kingdom

Références

Diabetes Care. 2012 Feb;35(2):265-72
pubmed: 22210568
BMJ. 2015 Jan 21;350:g7873
pubmed: 25609052
Methods Inf Med. 1998 Jan;37(1):64-8
pubmed: 9550849
Diabetologia. 2012 Nov;55(11):2938-45
pubmed: 22893029
Circulation. 2009 Apr 7;119(13):1728-35
pubmed: 19307472
BMJ. 2014 Feb 06;348:g1088
pubmed: 24503058
Diabet Med. 2008 Jun;25(6):743-6
pubmed: 18544111
N Engl J Med. 2014 Apr 17;370(16):1514-23
pubmed: 24738668
Cardiovasc Diabetol. 2017 Aug 10;16(1):100
pubmed: 28797259
Diabetes Obes Metab. 2015 Aug;17(8):771-80
pubmed: 25929277
Health Bull (Edinb). 1993 Mar;51(2):72-9
pubmed: 8514493
N Engl J Med. 2018 Aug 16;379(7):633-644
pubmed: 30110583
Diabetologia. 2014 Aug;57(8):1542-51
pubmed: 24859435
Eur J Heart Fail. 2011 Feb;13(2):148-53
pubmed: 21037250
Diabet Med. 2011 Dec;28(12):1514-9
pubmed: 21883441
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
Heart. 2015 Aug;101(16):1318-24
pubmed: 26076939
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):708-17
pubmed: 25160842
Diabetes Care. 2015 Aug;38(8):1449-55
pubmed: 25986661
PLoS Med. 2012;9(10):e1001321
pubmed: 23055834
Womens Health (Lond). 2015 Nov;11(6):833-9
pubmed: 26368038
Lancet Diabetes Endocrinol. 2015 Feb;3(2):105-13
pubmed: 25466521
Diabetologia. 2011 Dec;54(12):3003-6
pubmed: 21959958
Diabetologia. 2009 Sep;52(9):1836-41
pubmed: 19603150
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Lancet Diabetes Endocrinol. 2016 Jun;4(6):537-47
pubmed: 27156051
Ann Epidemiol. 2014 Aug;24(8):581-7
pubmed: 24970491

Auteurs

Stephanie H Read (SH)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK. Stephanie.Read@ed.ac.uk.
Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. Stephanie.Read@ed.ac.uk.

Colin M Fischbacher (CM)

Information Services Division, NHS National Services Scotland, Edinburgh, UK.

Helen M Colhoun (HM)

Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Danijela Gasevic (D)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK.
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Joannes J Kerssens (JJ)

Information Services Division, NHS National Services Scotland, Edinburgh, UK.

David A McAllister (DA)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Naveed Sattar (N)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Sarah H Wild (SH)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH